147
Participants
Start Date
July 9, 2018
Primary Completion Date
October 10, 2018
Study Completion Date
October 23, 2018
CA-008
single-dose wound infiltration prior to surgical incision closure
Placebo
single-dose wound infiltration prior to surgical incision closure
Ketorolac
30mg IV administered intraoperatively
Acetaminophen
1000mg IV administered intraoperatively
Oxycodone
5mg PO prn post-surgery
Bupivacaine Hydrochloride
0.5% infiltration pre-surgery
Chesapeake Research Group, Pasadena
HD Research Corp, Houston
Lotus Clinical Research, LLC, Pasadena
Lead Sponsor
Concentric Analgesics
INDUSTRY